← Back to Search

Procedure

Same Day Discharge After Ablation for Atrial Fibrillation (FAST-AF Trial)

Q: Is there a possibility for me to join this experiment?

This study seeks 50 individuals who suffer from <a href="https://www.withpower.com/clinical-trials/atrial-fibrillation">atrial fibrillation</a>, aged between 19 and 74. To be eligible for enrolment, patients must satisfy the age requirements (18-75 years old), have a documented history of AF or atypical flutter, and commit to following <a href="https://www.withpower.com/clinical-trials/all">all</a> necessary protocols and post-study follow up procedures.

Q: Are there any vacancies available to participants in this trial?

According to clinicaltrials.gov, this experiment is presently recruiting participants who fit the criteria. This research was initially posted on December 1st 2022 and its details were most recently revised on November 18th 2021.

Q: Is the age of 85 or older an acceptable criterion for enrollment in this trial?

Nineteen to seventy-four year olds can apply for the trial; however, there are 11 trials specifically designed for teens and 474 studies that cater exclusively to seniors.

Q: What is the uppermost limit for participants in this clinical experiment?

Affirmative. According to the information hosted on clinicaltrials.gov, this investigation is actively recruiting participants with its initial posting date being December 1st 2022 and its most recent edit taking place November 18th 2021. The trial seeks 50 individuals from a solitary medical centre.

N/A

Waitlist Available

Research Sponsored by Massachusetts General Hospital

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age >18 - Age < 75 yr

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up day of the af ablation procedure

Awards & highlights

FAST-AF Trial Summary

This trial will determine if it is safe to discharge patients the same day after they have had a catheter ablation for atrial fibrillation.

Who is the study for?

This trial is for adults aged 18-75 with documented atrial fibrillation or atypical atrial flutter, who can follow the study's requirements and agree to post-study check-ins. It excludes those with uncontrolled medical conditions, heart failure, severe valve disease, mental impairments affecting consent or follow-up, certain surgical histories, extreme INR levels or BMI outside of 20-40 range, pregnant women, and AF due to reversible causes.Check my eligibility

What is being tested?

The study tests the safety and feasibility of sending patients home on the same day after a catheter ablation procedure for atrial fibrillation. This involves using new venous closure devices and technologies for early discharge from MGH hospital with follow-up calls on days one and three post-procedure.See study design

What are the potential side effects?

While not explicitly listed in this summary, potential side effects may include discomfort at the catheter insertion site due to use of venous closure device; however these are expected to be minimal given that same-day discharge is based on low complication rates.

FAST-AF Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 18 and 75 years old.

FAST-AF Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ day of the af ablation procedure

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~day of the af ablation procedure

This trial's timeline: 3 weeks for screening, Varies for treatment, and day of the af ablation procedure for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

The rate of successful same day discharge after AF ablation procedure

FAST-AF Trial Design

1Treatment groups

Experimental Treatment

Group I: Same day dischargeExperimental Treatment1 Intervention

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Massachusetts General HospitalLead Sponsor

2,929 Previous Clinical Trials

13,198,305 Total Patients Enrolled

15 Trials studying Atrial Fibrillation

65,683 Patients Enrolled for Atrial Fibrillation

Media Library

Catheter Ablation with Pulmonary Vein Isolation (Procedure) Clinical Trial Eligibility Overview. Trial Name: NCT04199702 — N/A

Atrial Fibrillation Research Study Groups: Same day discharge

Atrial Fibrillation Clinical Trial 2023: Catheter Ablation with Pulmonary Vein Isolation Highlights & Side Effects. Trial Name: NCT04199702 — N/A

Catheter Ablation with Pulmonary Vein Isolation (Procedure) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04199702 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there a possibility for me to join this experiment?

"This study seeks 50 individuals who suffer from atrial fibrillation, aged between 19 and 74. To be eligible for enrolment, patients must satisfy the age requirements (18-75 years old), have a documented history of AF or atypical flutter, and commit to following all necessary protocols and post-study follow up procedures."

Answered by AI

Are there any vacancies available to participants in this trial?

"According to clinicaltrials.gov, this experiment is presently recruiting participants who fit the criteria. This research was initially posted on December 1st 2022 and its details were most recently revised on November 18th 2021."

Answered by AI

Is the age of 85 or older an acceptable criterion for enrollment in this trial?

"Nineteen to seventy-four year olds can apply for the trial; however, there are 11 trials specifically designed for teens and 474 studies that cater exclusively to seniors."

Answered by AI

What is the uppermost limit for participants in this clinical experiment?

"Affirmative. According to the information hosted on clinicaltrials.gov, this investigation is actively recruiting participants with its initial posting date being December 1st 2022 and its most recent edit taking place November 18th 2021. The trial seeks 50 individuals from a solitary medical centre."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Feasibility and Safety of Same Day Discharge afTer Atrial Fibrillation Ablation

Moussa C Mansour 2023. "Feasibility and Safety of Same Day Discharge afTer Atrial Fibrillation Ablation". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04199702.